a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer
Recruiting
N/A
Interventional Study
Endometrial Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- ARNAS Civico Di Cristina Benfratelli Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary endpoint of the present prospective study is to assess the outcomes in terms of acute toxicity of post-operative stereotactic radiotherapy for endometrial cancer
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
* Age 18-80 years
* ECOG PS ≤ 2 or KPS ≥ 70%
* Patients diagnosed with endometrial cancer (endometrioid, serous cell, clear cell, carcinosarcoma) FIGO stage IB-IIIC1 candidate to post-operative external beam radiotherapy, based on molecular and histological findings
* Indications for chemotherapy an…
Contacts